MicrobiomeTrials

Search Trials
Conditions
Learn
About

Data source: ClinicalTrials.gov

This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.

Sign up for updates

Long Term Efficacy and Safety of Orlistat for Type 1 Hyperlipoproteinemia | MicrobiomeTrials

← Back to trials

NCT05816343

Long Term Efficacy and Safety of Orlistat for Type 1 Hyperlipoproteinemia

RecruitingPHASE2INTERVENTIONAL

Trial Details

Start: 2024-01-26Est. Completion: 2027-08-01

Enrollment target: 28 participants

Locations

UT southwestern Medical Center, Dallas, Texas, United States

Contact

Abhimanyu G [agarg], MDabhimanyu.garg@utsouthwestern.edu 2146482895

Abhimanyu G [agarg]abhimanyu.garg@utsouthwestern.edu 2146482895

Apply or Learn More on ClinicalTrials.gov

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.